ORTHOPEDIATRICS CORP Quarterly Debt-to-equity in % from Q2 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Orthopediatrics Corp quarterly Debt-to-equity history and growth rate from Q2 2018 to Q3 2024.
  • Orthopediatrics Corp Debt-to-equity for the quarter ending September 30, 2024 was 20.6 %, a 44.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 20.6 +6.29 +44.1% Sep 30, 2024
Q2 2024 16.5 +3.04 +22.6% Jun 30, 2024
Q1 2024 16 -2.5 -13.5% Mar 31, 2024
Q4 2023 15.1 -8.59 -36.2% Dec 31, 2023
Q3 2023 14.3 -15.7 -52.5% Sep 30, 2023
Q2 2023 13.4 -26.1 -66% Jun 30, 2023
Q1 2023 18.6 -19.2 -50.9% Mar 31, 2023
Q4 2022 23.7 -14.3 -37.7% Dec 31, 2022
Q3 2022 30 -8.39 -21.9% Sep 30, 2022
Q2 2022 39.5 +3.39 +9.39% Jun 30, 2022
Q1 2022 37.8 +2.45 +6.94% Mar 31, 2022
Q4 2021 38 +5.89 +18.3% Dec 31, 2021
Q3 2021 38.4 +8.36 +27.8% Sep 30, 2021
Q2 2021 36.1 -1.27 -3.4% Jun 30, 2021
Q1 2021 35.3 -9.76 -21.7% Mar 31, 2021
Q4 2020 32.2 -18.9 -37% Dec 31, 2020
Q3 2020 30 -27.4 -47.7% Sep 30, 2020
Q2 2020 37.4 -18.3 -32.9% Jun 30, 2020
Q1 2020 45.1 -9.87 -18% Mar 31, 2020
Q4 2019 51 -15 -22.7% Dec 31, 2019
Q3 2019 57.5 -24.1 -29.5% Sep 30, 2019
Q2 2019 55.7 -178 -76.1% Jun 30, 2019
Q1 2019 54.9 Mar 31, 2019
Q4 2018 66.1 Dec 31, 2018
Q3 2018 81.5 Sep 30, 2018
Q2 2018 234 Jun 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.